They performed detailed binding analysis with C64 and proved that it was a more potent inhibitor than the other identified inhibitors targeting the Rbx1 binding site in CUL family proteins and further hindering the degradation of tumor-suppressive substrates, suggesting that the Rbx1 peptide was a possible inhibitor of the E3 ligase complex132. Here, RBX1 is linked to neoplasm.